Am J Transplant, Volume 21, Suppl 3 Archives - Page 42 of 139 - ATC Abstracts

2021 American Transplant Congress
Effects of Transverse Abdominis Plane Blocks on Opioid Requirements Post Kidney Donation
R. Caputo, O. Witkowsky, A. Rajab
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: There is lacking data regarding the use of transverse abdominis plane (TAP) blocks to reduce post-operative opioid requirements in kidney donors (KD). TAP blocks…
2021 American Transplant Congress
Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation
A. Chang¹, K. Cederquist¹, P. Abt¹, G. Wang², B. Jackson², A. Naji¹
¹Transplant Surgery, University of Pennsylvania, Philadelphia, PA, ²Vascular Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: In this study, we review our centers experience with complex renal artery aneurysms using our preferred technique of open nephrectomy, ex vivo repair, and…
2021 American Transplant Congress
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
M. Anand, S. Barhorst, S. Bumb, B. Abu Jawdeh, T. Kaur, A. Govil
University of Cincinnati, Cincinnati, OH
*Purpose: Medically complex donors are increasingly being assessed for donation. Due to concern for donor safety, there is a wide variation amongst transplant providers in…
2021 American Transplant Congress
Understanding Delays to Pediatric Kidney Transplant Wait-List Activation: Providers and Families Weigh in
C. M. Farkas-Skiles¹, A. Feinsinger², R. Pines³, A. D. Waterman⁴
¹Pediatric Nephrology, UCLA Mattel Children Hospital, Los Angeles, CA, ²Medicine and Philosophy, UCLA, Los Angeles, CA, ³Santa Barbara Cottage Hospital, Santa Barbara, CA, ⁴Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Since timely access to kidney transplant mediates mortality of children with kidney disease, we examined which factors most commonly affect providers’ decision-making to delay…
2021 American Transplant Congress
Outcomes of Kidney Transplant Recipients with Antibody-mediated Allograft Rejection: A Retrospective Study
A. Al Jurdi¹, L. Goldfarb¹, M. Lafargue², J. Azzi³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²Université de Paris, Paris, France, ³Transplantation Research Center, Brigham and Women’s Hospital, Boston, MA
*Purpose: The optimal regimen for treating acute and chronic antibody-mediated rejection (AMR) in kidney transplant recipients has yet to be established. The purpose of the…
2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection After Change in Maintenance Immunosuppression Regimens in the First Year Post Kidney Transplant
M. Walsh, V. Peev, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey
Rush University Medical Center, Chicago, IL
*Purpose: The purpose of this study was to investigate whether the use of donor-derived cell-free DNA (dd-cfDNA) is an effective screening tool for allograft rejection…
2021 American Transplant Congress
Outcomes of Kidney Transplantation in Patients with Congenital Anomalies of the Kidney and Urinary Tract
O. A. Oto¹, Y. Caliskan², H. Yazici¹, S. Mirioglu³, A. Dirim¹, N. Garayeva¹, S. Safak¹, E. Demir¹, Y. Ozluk⁴, A. Artan¹, A. Turkmen¹, K. Lentine²
¹Nephrology, Istanbul University, Istanbul, Turkey, ²Nephrology, Saint Louis University School of Medicine, Saint Louis, WA, ³Nephrology, Bezmialem Vakif University School of Medicine, Istanbul, Turkey, ⁴Pathology, Istanbul University, Istanbul, Turkey
*Purpose: We aimed to compare the long-term outcomes after kidney transplantation (KTx) in patients with congenital anomalies of the kidney and urinary tract (CAKUT) versus…
2021 American Transplant Congress
First Promising Results of CIAT: A New Kidney Exchange Program for Difficult-to-match Patients
M. de Klerk¹, J. Kal¹, K. Glorie², D. Roelen³, M. Betjes¹, J. Wetering van de¹, M. Kho¹, J. Roodnat¹
¹Erasmus MC, Rotterdam, Netherlands, ²EQI, Erasmus University, Rotterdam, Netherlands, ³LUMC, Leiden, Netherlands
*Purpose: Computerised Integration of Alternative Transplantation (CIAT) programs was developed to increase the chances of highly immunized (HI) and longwaiting (LW) kidney transplant candidates. CIAT…
2021 American Transplant Congress
The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients
M. Molinari¹, C. F. Carillo², D. Dongling¹, D. Jorgensen¹, S. Dharmayan¹, C. Kaltenmeier¹, H. Liu¹, J. Behari¹, V. Rachakonda¹, S. Ganesh¹, C. Hughes¹, A. Tevar¹, H. Al Harakeh¹, B. Emmanuel¹, A. Humar¹, R. Bataller¹
¹University of Pittsburgh Medical Centre, Pittsburgh, PA, ²Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA
*Purpose: Simultaneous portal vein thrombosis (PVT) and renal dysfunction (RD) have unknown effects after liver transplant (LT). We analyzed the outcomes of patients with simultaneous…
2021 American Transplant Congress
Varicella Hepatitis Mimicking Immune Checkpoint Inhibitor-induced Liver Toxicity
M. J. Weiss¹, X. Zhang², E. K. Spengler¹
¹Gastroenterology and Hepatology, University of Wisconsin, Madison, WI, ²Pathology, University of Wisconsin, Madison, WI
*Purpose: Nivolumab is an anti-PD-1 monoclonal antibody belonging to a class of immune checkpoint inhibitors (ICI) used for many malignancies. A major limitation to their…